Stock Events

Stock Events

Provexis 

€0.007000
8
-€0.00-6.67%Thursday 07:04

Statistics

Day High
0.007
Day Low
0.007
52W High
0.02
52W Low
0.0005
Volume
-
Avg. Volume
-
Mkt Cap
16.42M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Sep 27Expected
Q3 2022
Q2 2023
Q3 2023
Q2 2024
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-39.78%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.45MRevenue
-575,977.02Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NZCA.F. It's not an investment recommendation.
Taylor Wimpey
2
TW.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Unilever
ULVR.LSE
Mkt Cap99.03B
GSK
GSK.LSE
Mkt Cap78.89B
Admiral Group
ADM.LSE
Mkt Cap10.86B
Kraft Heinz
KHC
Mkt Cap28.86B
Kraft Heinz focuses on food and beverage products, including health and wellness items that compete with Provexis' offerings.
Campbells Co)
CPB
Mkt Cap6.39B
Campbell Soup Company, through its health and well-being products, competes in the same market as Provexis.
Hershey Company
HSY
Mkt Cap33.28B
The Hershey Company has expanded into health-focused snacks and products, positioning it as a competitor in the functional foods market.

About

Operating globally, Provexis plc, along with its associated companies, specializes in the creation, licensing, and commercialization of functional foods, medical nutritional products, and dietary supplements. A key offering is Fruitflow, a unique tomato extract designed to reduce the tendency for abnormal blood clot formation, which is linked to severe cardiovascular conditions such as heart attacks and strokes. This versatile extract is available in syrup and powder formats for integration into various food and beverage items, as well as dietary supplements. The company also provides Fruitflow + Omega-3, a capsule-based supplement aimed at fostering healthy blood circulation and supporting normal cardiac function. Provexis plc holds a strategic collaboration agreement with By-Health Co., Ltd. Its products are distributed through both physical retail channels and digital online platforms. Founded in 1999, Provexis plc has its headquarters situated in Reading, United Kingdom.
Show More
CEO
Ian Ford
Employees
2
Country
United Kingdom
ISIN
GB00B0923P27
WKN
000A0ETZW

Listings

STU
DE
NZCA.STU
F
DE
NZCA.F
LSE
GB
PXS.LSE

0 Comments

Share your thoughts

FAQs

What is Provexis stock price today?▼
The current price of NZCA.F is €0.01 EUR — it has decreased by -6.67% in the past 24 hours. Watch Provexis stock price performance more closely on the chart.
What is Provexis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Provexis stocks are traded under the ticker NZCA.F.
Is Provexis stock price growing?▼
NZCA.F stock has fallen by -6.67% compared to the previous week, the month change is a -30% fall, over the last year Provexis has showed a +1,300% increase.
What is Provexis market cap?▼
Today Provexis has the market capitalization of 16.42M
What is Provexis revenue for the last year?▼
Provexis revenue for the last year amounts to 1.45M EUR.
What is Provexis net income for the last year?▼
NZCA.F net income for the last year is -575,977.02 EUR.
How many employees does Provexis have?▼
As of November 2, 2026, the company has 2 employees.
In which sector is Provexis located?▼
Provexis operates in the Health & Wellness sector.
When did Provexis complete a stock split?▼
Provexis has not had any recent stock splits.
Where is Provexis headquartered?▼
Provexis is headquartered in Reading, United Kingdom.